|
顯示項目 543081-543090 / 2348973 (共234898頁)
<< < 54304 54305 54306 54307 54308 54309 54310 54311 54312 54313 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2014 |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
de Azambuja, Evandro; Holmes, Andrew P.; Piccart-Gebhart, Martine; Holmes, Eileen; Di Cosimo, Serena; Swaby, Ramona F.; Untch, Michael; Jackisch, Christian; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H.; Perez, Edith A.; Azim, Hatem A., Jr.; Kim, Sung-Bae; Kuemmel, Sherko; Huang, Chiun-Sheng; Vuylsteke, Peter; Hsieh, Ruey-Kuen; Gorbunova, Vera; Eniu, Alexandru; Dreosti, Lydia; Tavartkiladze, Natalia; Gelber, Richard D.; Eidtmann, Holger; Baselga, Jose; 黃俊升 |
| 臺大學術典藏 |
2018-09-10T15:02:13Z |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
de Azambuja, E. and Holmes, A.P. and Piccart-Gebhart, M. and Holmes, E. and Di Cosimo, S. and Swaby, R.F. and Untch, M. and Jackisch, C. and Lang, I. and Smith, I. and Boyle, F. and Xu, B. and Barrios, C.H. and Perez, E.A. and Azim, H.A. and Kim, S.-B. and Kuemmel, S. and Huang, C.-S. and Vuylsteke, P. and Hsieh, R.-K. and Gorbunova, V. and Eniu, A. and Dreosti, L. and Tavartkiladze, N. and Gelber, R.D. and Eidtmann, H. and Baselga, J.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-23T07:19:13Z |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J. |
| 中國醫藥大學 |
2013-12-31 |
Lapatinib 脫靶效應增強HDAC抑制劑對三陰性乳癌治療效果之探討
|
葉名焮(Ming-Hsin, Alex, Yeh);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2013-11 |
Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
|
(Yun-Ju Chen);葉名焮(Ming-Hsin, Alex, Yeh);游孟潔(Meng-Chieh Yu);魏雅鈴(Ya-Ling Wei);(Wen-Shu Chen);(Jhen-Yu Chen);(Chih-Yu Shih);涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);夏德椿(Te-Chun Hsia);(Pei-Hsuan Chien);(Shu-Hui Liu);余永倫(Yung-Luen Yu);黃偉謙(Wei-Chien Huang)* |
| 亞洲大學 |
2013 |
Lapatinib-mediated COX-2 expression via EGFR/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells
|
Hsia, Te-Chun;Hsia, Te-Chun;Hsia, Te-Chun;Hsia, Te-Chun;Chen, Yun-Ju;Chen, Yun-Ju;Wei, Ya-Ling;Wei, Ya-Ling;Meng-Chieh, Y;Yu, Meng-Chieh;Sheng-Chie, H;Hsu, Sheng-Chie;Shing-Ling, T;Tsai, Shing-Ling;Chen, Wen-Shu;Chen, Wen-Shu;Ming-Hsin, Alex, Yeh,;余永倫;Yu, Yung-luen;Hua, Tzungchi;Huang, Tzungchi;Hu, Chih-Yang;Huang, Chih-Yang;Hu, Mien-Chie;Hung, Mien-Chie |
| 義守大學 |
2013-04 |
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
|
Te-Chun Hsia;Chih-Yen Tu;Yun-Ju Chen;Ya-Ling Wei;Meng-Chieh Yu;Sheng-Chie Hsu;Shing-Ling Tsai;Wen-Shu Chen;Ming-Hsin Yeh;Chia-Jui Yen;Yung-Luen Yu;Tzung-Chi Huang;Chih-Yang Huang;Mien-Chie Hung;Wei-Chien Huang |
| 國立成功大學 |
2013-04 |
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
|
Hsia, Te-Chun; Tu, Chih-Yen; Chen, Yun-Ju; Wei, Ya-Ling; Yu, Meng-Chieh; Hsu, Sheng-Chie; Tsai, Shing-Ling; Chen, Wen-Shu; Yeh, Ming-Hsin; Yen, Chia-Jui; Yu, Yung-Luen; Huang, Tzung-Chi; Huang, Chih-Yang; Hung, Mien-Chie; Huang, Wei-Chien |
| 中國醫藥大學 |
2013-09-28 |
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
|
夏德椿(Te-Chun Hsia);涂智彥(Chih-Yen Tu);陳韻如(Yun-Ju Chen);魏雅鈴(Ya-Ling Wei);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2015-06-29 |
Lapatinibenhances migration ability of triple-negative breast cancer cells through induction of Raf-1/MAPK-dependent interleukin-6 expression by downergulationof microRNA-7
|
蕭宇君(Yu-Chun Hsiao);陳韻如(Yun-Ju Chen);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
顯示項目 543081-543090 / 2348973 (共234898頁)
<< < 54304 54305 54306 54307 54308 54309 54310 54311 54312 54313 > >>
每頁顯示[10|25|50]項目
|
